Deerfield Management Company, L.P. (Series C) Vera Therapeutics, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.37 Billion
- Q3 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,641,157 shares of VERA stock, worth $103 Million. This represents 1.96% of its overall portfolio holdings.
Number of Shares
3,641,157
Previous 3,348,117
8.75%
Holding current value
$103 Million
Previous $78.9 Million
33.68%
% of portfolio
1.96%
Previous 1.81%
Shares
6 transactions
Others Institutions Holding VERA
# of Institutions
195Shares Held
65.9MCall Options Held
128KPut Options Held
172K-
Avoro Capital Advisors LLC New York, NY6.21MShares$176 Million2.46% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.03MShares$114 Million9.86% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.67MShares$104 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$94.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.19MShares$90.4 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $766M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...